| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.005 |